FibroGen Inc (FGEN) stock news · rev $6.4M
FibroGen Inc (FGEN) is a biotechnology company listed on NASDAQ.
This FGEN news page leads with what FibroGen Inc filed — not a scraped headline mill.
No cached 8-K sentence for FGEN yet. We will not pad this page with generic market recap.
Latest reported FGEN revenue for 2025-12-31 was $6.4M. Net income was $183.5M. Revenue was down 95.6% from 2023-12-31 to 2025-12-31. FGEN currently screens at market cap $39.3M.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the FGEN stock page; for the tape open the quote page.
FGEN stock news FAQ
What are FGEN's latest revenue and net income?
Latest cached FibroGen Inc (FGEN) revenue for Dec 31, 2025 was $6.4M. Net income was $183.5M. Statements: https://lician.com/financials/fgen
How did FGEN revenue change from the prior cached period?
Cached FibroGen Inc (FGEN) revenue was down 95.6% from $147.8M (Dec 31, 2023) to $6.4M (Dec 31, 2025). Statements: https://lician.com/financials/fgen
What is FGEN's market cap?
FibroGen Inc (FGEN) market cap is $39.3M on the latest cached fundamentals snapshot.
What kind of company is FGEN?
FibroGen Inc (FGEN) is a biotechnology company listed on NASDAQ.
Where is FGEN stock news listed?
Cached stock news for FibroGen Inc (FGEN) is listed at https://lician.com/news/fgen. Filings: https://lician.com/sec/fgen
Not investment advice.